Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Investigators based at the Kennedy Institute of Rheumatology, NDORMS have recently received CRUK awards to increase understanding of a variety of cancers and immunotherapy.

Audrey Gérard

Audrey Gérard, has been awarded a CRUK Immunology Project Award to look at the mechanisms inhibiting anti-tumour immunity. There has been unprecedented success in treating aggressive cancers with checkpoint blockade, immunotherapy that stimulates the body's own immune system to eliminate cancer cells. But more research is needed to determine whether there are other checkpoints restricting tumour immunity that could be therapeutically exploited to improve treatment where there has been less success.

"This award is a fantastic opportunity for us to expand our fundamental work on the feedback mechanisms regulating the immune system. It will allow us to investigate how this regulation is co-opted by cancer cells to evade the immune system."

Anjali Kusumbe, Richard Williams and Felix Clanchy

Anjali Kusumbe, Richard Williams and Felix Clanchy were granted a CRUK Early Detection Primer Award to research Ewing's Sarcoma, a highly malignant tumour that occurs in the bone or surrounding tissue, usually treated with chemotherapy and surgery or radiotherapy. But the spread of the disease and recurrence after therapy is associated with poor prognosis. To detect recurrence, patients undertake periodic chest X-rays, blood tests and remain vigilant for symptoms such as bone pain. The research proposes to improve the current method for the detection of relapse or occult disease at the end of treatment.

"This project brings together Anjali, Richard and Felix as researchers with an interest in bone cancer, pain, and detection of rare cells respectively. The funding will allow the team to consolidate and extend previous work in the development of models and tools to stratify patients according to risk of disease."

Alex Clarke

With his Cancer Immunology grant, Alex Clarke will explore how one-carbon (1C) metabolism in germinal centre B cells promotes autoimmunity and lymphoma. The aim of this project is to study and interfere with a vital pathway in which cells synthesise the amino acid serine from glucose, an important building block for cell growth.

"This award provides an exciting opportunity to apply the expertise my lab has developed in immune metabolism to understanding the origins of lymphoma, which we often see complicating autoimmune disease. We hope that identifying metabolic pathways shared between autoimmune B cells and lymphoma will pave the way for new treatment approaches which can be used across both diseases."

Similar stories

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

Vascular loss shown to be the primary hallmark of aging

Kennedy Main Tissue remodelling and regeneration

New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.

Understanding the first wave of COVID-19 and implications for tackling the ongoing pandemic: evidence from 5.5 million people from Catalonia, Spain

Botnar Main Research Statistics and epidemiology

Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.